Literature DB >> 24646799

Hiding in plain sight: molecular genetics applied to giant congenital melanocytic nevi.

Heather C Etchevers1.   

Abstract

Large and giant congenital melanocytic nevi are rare malformations that offer surprising insight into prenatal and postnatal acquisition of nevi of any size, central and peripheral nervous system development, and melanomagenesis. In this issue, Charbel et al. demonstrate the use of highly sensitive detection techniques for recurrent but difficult-to-detect mutations in NRAS and BRAF. It is now possible to systematically add a molecular qualifier to distinguish lesions that had once been considered to be equivalent based on the single visual parameter of size. These findings help to elucidate the pathophysiology of congenital melanocytic nevi and their predisposition to malignancy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24646799     DOI: 10.1038/jid.2013.531

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Genotypic and gene expression studies in congenital melanocytic nevi: insight into initial steps of melanotumorigenesis.

Authors:  Barbara Dessars; Linda E De Raeve; Renato Morandini; Anne Lefort; Hakim El Housni; Ghanem E Ghanem; Benoît J Van den Eynde; Wenbin Ma; Diane Roseeuw; Gilbert Vassart; Frédérick Libert; Pierre Heimann
Journal:  J Invest Dermatol       Date:  2008-07-17       Impact factor: 8.551

2.  NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.

Authors:  Christelle Charbel; Romain H Fontaine; Gabriel G Malouf; Arnaud Picard; Natacha Kadlub; Nizar El-Murr; Alexandre How-Kit; Xiaoping Su; Aurore Coulomb-L'Hermine; Jorg Tost; Samia Mourah; Selim Aractingi; Sarah Guégan
Journal:  J Invest Dermatol       Date:  2013-10-15       Impact factor: 8.551

3.  New recommendations for the categorization of cutaneous features of congenital melanocytic nevi.

Authors:  Sven Krengel; Alon Scope; Stephen W Dusza; Reinhard Vonthein; Ashfaq A Marghoob
Journal:  J Am Acad Dermatol       Date:  2012-09-13       Impact factor: 11.527

Review 4.  The risk of melanoma and neurocutaneous melanosis associated with congenital melanocytic nevi.

Authors:  Kara N Shah
Journal:  Semin Cutan Med Surg       Date:  2010-09

5.  Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases.

Authors:  Pushkar A Phadke; Dinesh Rakheja; Long P Le; Maria Angelica Selim; Payal Kapur; Amy Davis; Martin C Mihm; Mai P Hoang
Journal:  Am J Surg Pathol       Date:  2011-05       Impact factor: 6.394

6.  Lack of BRAF(V600E) mutations in giant congenital melanocytic nevi in a Chinese population.

Authors:  Di Wu; Mei Wang; Xingang Wang; Ningbei Yin; Tao Song; Haidong Li; Jun Yu; Duen-Mei Wang; Zhenmin Zhao
Journal:  Am J Dermatopathol       Date:  2011-06       Impact factor: 1.533

7.  Chronic itch development in sensory neurons requires BRAF signaling pathways.

Authors:  Zhong-Qiu Zhao; Fu-Quan Huo; Joseph Jeffry; Lori Hampton; Shadmehr Demehri; Seungil Kim; Xian-Yu Liu; Devin M Barry; Li Wan; Zhong-Chun Liu; Hui Li; Ahu Turkoz; Kaijie Ma; Lynn A Cornelius; Raphael Kopan; James F Battey; Jian Zhong; Zhou-Feng Chen
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

8.  Inducible expression of (V600E) Braf using tyrosinase-driven Cre recombinase results in embryonic lethality.

Authors:  Nathalie Dhomen; Silvy Da Rocha Dias; Robert Hayward; Lesley Ogilvie; Douglas Hedley; Veronique Delmas; Afshan McCarthy; Deborah Henderson; Caroline J Springer; Catrin Pritchard; Lionel Larue; Richard Marais
Journal:  Pigment Cell Melanoma Res       Date:  2009-12-11       Impact factor: 4.693

9.  Primary melanoma of the CNS in children is driven by congenital expression of oncogenic NRAS in melanocytes.

Authors:  Malin Pedersen; Heidi V N Küsters-Vandevelde; Amaya Viros; Patricia J T A Groenen; Berta Sanchez-Laorden; Jacobus H Gilhuis; Ilse A van Engen-van Grunsven; Willy Renier; Jolanda Schieving; Ion Niculescu-Duvaz; Caroline J Springer; Benno Küsters; Pieter Wesseling; Willeke A M Blokx; Richard Marais
Journal:  Cancer Discov       Date:  2013-01-09       Impact factor: 39.397

10.  Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.

Authors:  Veronica A Kinsler; Anna C Thomas; Miho Ishida; Neil W Bulstrode; Sam Loughlin; Sandra Hing; Jane Chalker; Kathryn McKenzie; Sayeda Abu-Amero; Olga Slater; Estelle Chanudet; Rodger Palmer; Deborah Morrogh; Philip Stanier; Eugene Healy; Neil J Sebire; Gudrun E Moore
Journal:  J Invest Dermatol       Date:  2013-02-07       Impact factor: 8.551

  10 in total
  3 in total

1.  Oncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.

Authors:  Francis Shih; Stephen Yip; Patrick J McDonald; Albert E Chudley; Marc R Del Bigio
Journal:  Acta Neuropathol Commun       Date:  2014-10-21       Impact factor: 7.801

2.  Giant Congenital Melanocytic Nevi: An Update and Emerging Therapies.

Authors:  Girish Gulab Meshram; Neeraj Kaur; Kanwaljeet Singh Hura
Journal:  Case Rep Dermatol       Date:  2018-02-08

Review 3.  Neurological signs, symptoms and MRI abnormalities in patients with congenital melanocytic naevi and evaluation of routine MRI-screening: systematic review and meta-analysis.

Authors:  Anne C Fledderus; Anna Linn Widdershoven; Oren Lapid; Corstiaan C Breugem; Suzanne G M A Pasmans; Chantal M A M van der Horst; Marc M Engelen; Phyllis I Spuls
Journal:  Orphanet J Rare Dis       Date:  2022-03-02       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.